Product Name: G-alpha(q) (206-212)
Product Number: PE-01BFQ99
| Size: | 200 µg | Price: | 29.00 | |
| 1 mg | $US | 59.00 | ||
| 5 mg | 129.00 |
Peptide Name: G-alpha(q) (206-212)
Product Use: The Q209P oncogenic mutation, which results in constiutive activation of the G protein, is commonly found in many human tumours.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: VGGPRSE
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: βAla-Cys
Peptide Molecular Mass Calculated: 873.9 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Product Use: The Q209P oncogenic mutation, which results in constiutive activation of the G protein, is commonly found in many human tumours.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: VGGPRSE
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: βAla-Cys
Peptide Molecular Mass Calculated: 873.9 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Storage Conditions: -20°C
Scientific Background: G-alpha(q) (GNAQ) is a guanine nucleotide-binding protein (G protein) that regulates B-cell selection and survival and is required to prevent B-cell-dependent autoimmunity. It may also regulates chemotaxis of BM-derived neutrophils and dendritic cells.
© Kinexus Bioinformatics Corporation 2017